{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T01:50:56Z","timestamp":1769910656836,"version":"3.49.0"},"reference-count":39,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"unspecified","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"The Veterans Administration Medical Center in Memphis"},{"name":"Natural Science Foundation of Heilongjiang Province, PR China","award":["LH2019H063"],"award-info":[{"award-number":["LH2019H063"]}]},{"name":"UTHSC","award":["R073290110"],"award-info":[{"award-number":["R073290110"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Ophth"],"accepted":{"date-parts":[[2025,3,28]]},"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To compare the genetic characteristics of the normal control group to those of neovascular age-related macular degeneration (AMD) patients and to detect single-nucleotide polymorphisms (SNPs) related to the pathogenesis of neovascular AMD and the sensitivity to anti-VEGF drug, combercept.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>This is a prospective case-controlled study. A total of 104 neovascular AMD patients were treated with combercept and 106 normal subjects were served as the control group. SNPs associated with neovascular AMD and disease susceptibility and drug sensitivity were analysed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Significant differences existed between neovascular AMD patients and normal subjects among genotypes of the SNPs of two genes, ARMS2 (rs10490924 T) and HTRA 1 (rs11200638 A). The T alleles in rs1065489 of CFH and the rs2230205 of C3 significantly promoted neovascular AMD in males while having no significant effect in females. Six SNPs of five genes, including C3 (rs2250656 G), CFB (rs2072633 G), CFH (rs2274700 A, rs3766405 T), KDR (rs6828477 A) and FZD 4 (rs10898563 T), had significant impact in reducing neovascular AMD. Two SNPs of the CFH gene (rs2274700 A and rs3766405 T) and one SNP of the CFB gene, rs2072633 G, were statistically significantly associated with good response to combercept. Conversely, the other two SNPs of the CFH gene, rs1065489 T and rs3753396 G, and the rs7412 T of the APOE gene were associated with a relatively poor patient response to drug action. Two sets of SNPs of CFB have a combined positive effect on disease. The two SNPs of CFH (rs1065489 T and rs3753396 G) and the combination of the two SNPs of CFH and rs7412T of APOE have negative effects on the drug effectiveness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These genotype differences facilitate the selection of individualised treatment options towards obtaining the most efficacious clinical treatment. These findings need to be validated by studies with different ethnic populations and\/or larger samples.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjophth-2024-001872","type":"journal-article","created":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T17:55:12Z","timestamp":1744480512000},"page":"e001872","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Genotypes of SNPs of key genes regulate susceptibility and drug sensitivity to neovascular AMD in the human population"],"prefix":"10.1136","volume":"10","author":[{"given":"Jinglin","family":"Cui","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, The First Hospital of Qiqihar City, Qiqihar, Heilongjiang, China"},{"name":"Biomedical Sciences, University of Tennessee Health Science Center, Memphis, Tennessee, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hang","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, The First Hospital of Qiqihar City, Qiqihar, Heilongjiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suoxi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, The First Hospital of Qiqihar City, Qiqihar, Heilongjiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuo","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, The First Hospital of Qiqihar City, Qiqihar, Heilongjiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiande","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, The First Hospital of Qiqihar City, Qiqihar, Heilongjiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Xiu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, The First Hospital of Qiqihar City, Qiqihar, Heilongjiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boyang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, The First Hospital of Qiqihar City, Qiqihar, Heilongjiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayao","family":"Li","sequence":"additional","affiliation":[{"name":"Mudanjiang Medical University, Mudanjiang, Heilongjiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaoming","family":"Jin","sequence":"additional","affiliation":[{"name":"Mudanjiang Medical University, Mudanjiang, Heilongjiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anqi","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, The First Hospital of Qiqihar City, Qiqihar, Heilongjiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyang","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, The First Hospital of Qiqihar City, Qiqihar, Heilongjiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawei","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica M","family":"Jablonski","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Tennessee Health Science Center, Memphis, Tennessee, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Genetics, Genomics and Informatics, University of Tennessee Health Science Center, Memphis, Tennessee, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1112-8088","authenticated-orcid":false,"given":"Weikuan","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, The University of Tennessee Health Science Center, Memphis, Tennessee, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baofeng","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Ministry of Education, Brasilia, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,4,12]]},"reference":[{"key":"2026010721202937000_10.1.e001872.1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.122.4.598"},{"key":"2026010721202937000_10.1.e001872.2","first-page":"106","article-title":"Analysis of the epidemiological burden of age-related macular degeneration in China based on the data of global burden of disease","volume":"48","author":"Lin","year":"2023","journal-title":"J Cent South Univ"},{"key":"2026010721202937000_10.1.e001872.3","doi-asserted-by":"publisher","DOI":"10.3109\/08820538.2011.577129"},{"key":"2026010721202937000_10.1.e001872.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2008.05.002"},{"key":"2026010721202937000_10.1.e001872.5","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1097\/IAE.0000000000001876","article-title":"DIFFERENCE IN TREATMENT OUTCOMES ACCORDING TO OPTICAL COHERENCE TOMOGRAPHY-BASED STAGES IN TYPE 3 NEOVASCULARIZATION (RETINAL ANGIOMATOUS PROLIFERATION)","volume":"38","author":"Kim","year":"2018","journal-title":"Retina"},{"key":"2026010721202937000_10.1.e001872.6","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/eye.2017.187","article-title":"Comparison of effectiveness and safety between conbercept and ranibizumab for treatment of neovascular age-related macular degeneration. A retrospective case-controlled non-inferiority multiple center study","volume":"32","author":"Cui","year":"2018","journal-title":"Eye (Lond)"},{"key":"2026010721202937000_10.1.e001872.7","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2147\/OPTH.S106092","article-title":"Ranibizumab in monotherapy and combined with photodynamic therapy for retinal angiomatous proliferation","volume":"10","author":"Arias","year":"2016","journal-title":"Clin Ophthalmol"},{"key":"2026010721202937000_10.1.e001872.8","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2147\/OPTH.S31016","article-title":"Emerging roles for antiangiogenesis factors in management of ocular disease","volume":"6","author":"Saeed","year":"2013","journal-title":"Clin Ophthalmol"},{"key":"2026010721202937000_10.1.e001872.9","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.2217\/pgs.13.100","article-title":"Pharmacogenetic labyrinth of neovascular age-related macular degeneration therapy: how to escape and move forward?","volume":"14","author":"Lazzeri","year":"2013","journal-title":"Pharmacogenomics"},{"key":"2026010721202937000_10.1.e001872.10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000337154","article-title":"Neovascular age-related macular degeneration","volume":"227 Suppl 1","author":"Veritti","year":"2012","journal-title":"Ophthalmologica"},{"key":"2026010721202937000_10.1.e001872.11","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2006.113902"},{"key":"2026010721202937000_10.1.e001872.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2013.01.014"},{"key":"2026010721202937000_10.1.e001872.13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1102673"},{"key":"2026010721202937000_10.1.e001872.14","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2016-308815"},{"key":"2026010721202937000_10.1.e001872.15","unstructured":"Cui J . Genotypes of SNPS of key genes regulate susceptibility and drug sensitivity to neovascular AMD. The University of Tennessee Health Science Center ProQuest Dissertations & Theses; 2024.31299374. Available: https:\/\/www.proquest.com\/docview\/3072618448"},{"key":"2026010721202937000_10.1.e001872.16","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000019007","article-title":"Different conbercept injection strategies for the treatment of exudative age-related macular degeneration: A retrospective cohort study","volume":"99","author":"Gao","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"2026010721202937000_10.1.e001872.17","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(20)30489-7"},{"key":"2026010721202937000_10.1.e001872.18","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.ophtha.2010.12.030","article-title":"Prevalence of Age-Related Macular Degeneration in a Rural Chinese Population: The Handan Eye Study","volume":"118","author":"Yang","year":"2011","journal-title":"Ophthalmology"},{"key":"2026010721202937000_10.1.e001872.19","first-page":"10","article-title":"Pathogenesis and treatment of dry age-related macular degeneration","volume":"42","author":"Zhang","year":"2022","journal-title":"Recent Advances in Ophthalmology"},{"key":"2026010721202937000_10.1.e001872.20","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jmgm.2017.12.023","article-title":"Exploring the association of rs10490924 polymorphism with age-related macular degeneration: An in silico approach","volume":"80","author":"Jahanfar","year":"2018","journal-title":"J Mol Graph Model"},{"key":"2026010721202937000_10.1.e001872.21","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-016-0776-3","article-title":"Age-related macular degeneration associated polymorphism rs10490924 in ARMS2 results in deficiency of a complement activator","volume":"14","author":"Micklisch","year":"2017","journal-title":"J Neuroinflammation"},{"key":"2026010721202937000_10.1.e001872.22","doi-asserted-by":"crossref","DOI":"10.1186\/s40246-016-0079-x","article-title":"AMD and the alternative complement pathway: genetics and functional implications","volume":"10","author":"Tan","year":"2016","journal-title":"Hum Genomics"},{"key":"2026010721202937000_10.1.e001872.23","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-66014-7_7"},{"key":"2026010721202937000_10.1.e001872.24","doi-asserted-by":"crossref","first-page":"e691","DOI":"10.1111\/aos.14357","article-title":"An association of neovascular age-related macular degeneration with polymorphisms of CFH, ARMS2, HTRA1 and C3 genes in Czech population","volume":"98","author":"Matu\u0161kov\u00e1","year":"2020","journal-title":"Acta Ophthalmol"},{"key":"2026010721202937000_10.1.e001872.25","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/ahg.12311","article-title":"Association of rs10490924 in ARMS2\/HTRA1 with age-related macular degeneration in the Pakistani population","volume":"83","author":"Ayub","year":"2019","journal-title":"Ann Hum Genet"},{"key":"2026010721202937000_10.1.e001872.26","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.exer.2013.04.019","article-title":"Variants at chromosome 10q26 locus and the expression of HTRA1 in the retina","volume":"112","author":"Wang","year":"2013","journal-title":"Exp Eye Res"},{"key":"2026010721202937000_10.1.e001872.27","doi-asserted-by":"crossref","DOI":"10.1186\/s12881-020-01047-5","article-title":"HTRA1 rs11200638 variant and AMD risk from a comprehensive analysis about 15,316 subjects","volume":"21","author":"Liu","year":"2020","journal-title":"BMC Med Genet"},{"key":"2026010721202937000_10.1.e001872.28","doi-asserted-by":"publisher","DOI":"10.1126\/science.1133811"},{"key":"2026010721202937000_10.1.e001872.29","doi-asserted-by":"publisher","DOI":"10.1007\/s10038-007-0162-1"},{"key":"2026010721202937000_10.1.e001872.30","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2578"},{"key":"2026010721202937000_10.1.e001872.31","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01862","article-title":"Novel Association of High C-Reactive Protein Levels and A69S at Risk Alleles in Wet Age-Related Macular Degeneration Women","volume":"9","author":"Fernandez-Robredo","year":"2018","journal-title":"Front Immunol"},{"key":"2026010721202937000_10.1.e001872.32","doi-asserted-by":"crossref","DOI":"10.1038\/srep09424","article-title":"Ethnic differences in the association of SERPING1 with age-related macular degeneration and polypoidal choroidal vasculopathy","volume":"5","author":"Liu","year":"2015","journal-title":"Sci Rep"},{"key":"2026010721202937000_10.1.e001872.33","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.13-13437"},{"key":"2026010721202937000_10.1.e001872.34","doi-asserted-by":"publisher","DOI":"10.1007\/s12017-015-8342-1"},{"key":"2026010721202937000_10.1.e001872.35","first-page":"115","article-title":"The influence of genetics on response to treatment with ranibizumab (Lucentis) for age-related macular degeneration: the Lucentis Genotype Study (an American Ophthalmological Society thesis)","volume":"109","author":"Francis","year":"2011","journal-title":"Trans Am Ophthalmol Soc"},{"key":"2026010721202937000_10.1.e001872.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.10.006"},{"key":"2026010721202937000_10.1.e001872.37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.2010.02080.x"},{"key":"2026010721202937000_10.1.e001872.38","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.ophtha.2015.04.024","article-title":"VEGFR2 Gene Polymorphisms and Response to Anti-Vascular Endothelial Growth Factor Therapy in Age-Related Macular Degeneration","volume":"122","author":"Hagstrom","year":"2015","journal-title":"Ophthalmology"},{"key":"2026010721202937000_10.1.e001872.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.11.037"}],"container-title":["BMJ Open Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjophth-2024-001872","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T05:21:04Z","timestamp":1767849664000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjophth.bmj.com\/lookup\/doi\/10.1136\/bmjophth-2024-001872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,4,12]]},"published-print":{"date-parts":[[2025,4]]}},"alternative-id":["10.1136\/bmjophth-2024-001872"],"URL":"https:\/\/doi.org\/10.1136\/bmjophth-2024-001872","relation":{},"ISSN":["2397-3269"],"issn-type":[{"value":"2397-3269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4]]}}}